KIMBERLY BATES: Open Payments
NPI 1003392283 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,493 in 156 payments from 26 companies in 2025. Trend: 2023 $17 · 2024 $1,800 · 2025 $4,493
Food & beverage: $3,012Travel & lodging: $1,408Education: $73
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 4 | $1,555 |
| ABBVIE INC. | 21 | $377 |
| SK Life Science, Inc. | 18 | $339 |
| EMD Serono, Inc. | 11 | $306 |
| Alexion Pharmaceuticals, Inc. | 10 | $252 |
| ACADIA Pharmaceuticals Inc | 13 | $235 |
| Novartis Pharmaceuticals Corporation | 16 | $226 |
| UCB, Inc. | 13 | $183 |
| Axsome Therapeutics, Inc. | 4 | $172 |
| Teva Pharmaceuticals USA, Inc. | 7 | $152 |
Products named: VNS Therapy, ULTOMIRIS, NUPLAZID, QULIPTA, KESIMPTA, Symbravo, Rystiggo, PONVORY.
Industry payments across OH — which companies pay providers there.
